Mirindi Kabangu (@Mirindi_) header
Mirindi Kabangu (@Mirindi_) profile picture

MS4 | Incoming #RadRes | he/him | 🇨🇩

Indianapolis, IN
Joined April 2021
Photo by Mirindi Kabangu (@Mirindi_)
Mirindi Kabangu retweeted
I take absolutely no pleasure in being 100% right about this. First, JAMA published the misleading corporate propaganda piece claiming AI is better than physicians from authors who are all financially tied to medical AI companies. Now, the FDA has cited that very paper in its new AI roadmap entitled “A Clinical Super Intelligence Roadmap: Better Answers, Faster Care, and Lower Costs.” This is precisely how corporate propaganda seeps into legitimate policy, guiding federal focus and research funding towards venture capital returns and shareholder profit — and away from the public interest. It remains incredibly disappointing, yet entirely predictable, to see one of our most prestigious medical journals in JAMA co-opted to manipulate federal policy in ways that line the pockets of venture capitalists at the expense of patients and the physicians that care for them.
Some people have asked me why I’m making fun of that JAMA viewpoint piece so much. It’s because corporate propaganda is not benign. It influences both public sentiment and government policy. To issue a press release on your company’s website touting biased comparisons as evidence of your product’s efficacy is one thing. To publish what amounts to a corporate advertisement with the imprimatur of a prestigious peer-reviewed journal (albeit under the guise of a “viewpoint” piece) is entirely another — co-opting the legitimizing effects of journal publication to imply that somehow the scientific community has blessed your company’s product. The article in question will no doubt be used by its heavily conflicted authors to garner further investment for their companies and to lobby the government to shape CMS policy in their favor — giving further institutional credence, and potentially public money, to their proprietary technology. The AI hype cycle will continue with its air of inevitability, despite not having objectively demonstrated benefit to anyone apart from corporate shareholders.
6
71
3
338
18,973
Mirindi Kabangu retweeted
Nicolas, congratulations on discovering medical literature from the 1990s. Now perhaps you could read what happened afterward. Golding raised a legitimate concern in 1992. Scientists investigated it, as scientists should. A pooled analysis of six studies in 2002 found no convincing evidence that newborn vitamin K injections increased childhood leukemia. A larger British investigation in 2003 examined 2,530 children with cancer and 4,487 controls and likewise found no association. And that frightening sheep experiment? A human newborn study found no significant increase in chromosome abnormalities or sister-chromatid exchanges after vitamin K. You have presented decades-old findings while omitting the research that tested them. Meanwhile, vitamin K deficiency can cause fatal brain hemorrhages in newborns. Parents deserve the complete scientific record before making a decision that could cost their child a life or a functioning brain. Perhaps your next investigation could include reading past 1998.
🚨THREE STUDIES LINK NEWBORN VITAMIN K SHOTS TO HIGHER ODDS OF CHILDHOOD CANCER All three studies were published in the British Medical Journal: +165% odds of CHILDHOOD LEUKEMIA (Golding et al.) +97% odds of ALL CHILDHOOD CANCERS (Golding et al.) +79% odds of ACUTE LYMPHOBLASTIC LEUKEMIA (Parker et al.) +44% odds of CHILDHOOD CANCER (Passmore et al.) Over 93% of American newborns receive this injection, which can contain benzyl alcohol, polysorbate 80, propylene glycol, and aluminum — all of which are toxic to humans. Possible cancer mechanisms include genotoxic effects and chromosomal instability. In an experimental study, vitamin K1 increased sister-chromatid exchanges by 36.5% in fetal sheep within 24 hours of injection, with similar effects observed in cultured human cells. These exchanges may indicate altered DNA recombination or cellular stress, potentially relevant to genomic instability. Strangely, new large-scale investigations into this potential cancer link appear to have stopped over 20 years ago, despite multiple studies reporting statistically significant increases in childhood cancer odds.
Readers added context they thought people might want to know
Early 1990s claims of a cancer link were investigated and refuted by subsequent research, including a 1.38-million-child cohort, a 54,000-child US study, and large pooled analyses finding no link to leukemia. Research ceased because the hypothesis was disproven. pubmed.ncbi.nlm.nih.gov/8343734/ pubmed.ncbi.nlm.nih.gov/8361503/ pubmed.ncbi.nlm.nih.gov/11857013/ pubmed.ncbi.nlm.nih.gov/14520451/ pubmed.ncbi.nlm.nih.gov/12837888/ cdc.gov/vitamin-k-defi…
26
444
13
2,544
81,293
Mirindi Kabangu retweeted
Building a practice. Building a vision. Building a future neuroscience center. And building science. Today our international pediatric stroke study was published. More to come! #PediatricStroke #Research #Neurointervention
2
8
226
Mirindi Kabangu retweeted
I am uncomfortable with the proliferation of AI-generated radiology images in social media education. They're not labeled as AI and undiscerning viewers are routinely fooled into thinking they're real.
17
25
5
225
47,181
We are thrilled to welcome our incoming Diagnostic Radiology and Diagnostic Radiology-Interventional Radiology Integrated Residents, beginning July 1, 2026. Welcome to our team! 💛🖤 #Match2026 #radres #IRads #radiology
5
8
2
65
12,059
Mirindi Kabangu retweeted
A medical malpractice case about communication failures around imaging: 🧵 A young, very tall man with chest pain, nausea, and abdominal pain presented to the ED and was worked up by the emergency physician.
26
51
18
258
220,770
Mirindi Kabangu retweeted
We finally published "Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma" in @JAMANetworkOpen. Which provides a comprehensive look at the shifting treatment landscape for hepatocellar carcinoma #HCC. jamanetwork.com/journals/jam…
2
3
3
1,450
Mirindi Kabangu retweeted
Hot 🔥 off the press 🔥 Thrilled to share our recently published paper: THE GUIDEWIRE CROSSES BUT NOTHING ELSE DOES - A PICTORIAL REVIEW FREE downloading on VASA: econtent.hogrefe.com/doi/10.…
9
1
31
4,933
New publication in Interventional Neuroradiology! Our team reports successful use of intra-arterial bleomycin for treating labial AVMs in children — complete cure, no recurrence after 2 years. 🔗 doi.org/10.1177/088307382513…
3
5
38
1,949
Pediatric Neurointerventionalist @MeshaMartinezMD describes how inclusion and empathy shape better care in our latest #ACRMSS Behind the White Coat feature.
5
9
1,020
Mirindi Kabangu retweeted
From wires to wisdom — had a fantastic time rotating and learning with the IR team at UIHC. 💉📚
3
4
507
Research published by for-profit companies has nearly tripled, leading to rising APCs and excessive paywalls. So we started a nonprofit journal where you can publish and peer review for charity, or even get paid to peer review. Link 👇 #medtwitter #academia #research
2
2
13
1,311
Representation matters—especially in medicine. 🧠✊🏿 ASBN exists to uplift, connect, and amplify Black neurosurgeons across the country. But we can’t do it without YOU. Become a member today and help us continue building a powerful legacy of excellence, mentorship, and visibility for Black doctors everywhere. Join us at amsobns.org #BlackDoctorsMatter #ASBNOrg #Neurosurgery #RepresentationInMedicine
3
22
571
#MedStudents, this one's for you! 📣 Applications for the 2024 PIER Internship are open. This is THE premier opportunity to explore the #radiology specialty in-depth and engage in research. Learn more and apply: bit.ly/4gPMR8d
9
3
13
5,247
Mirindi Kabangu retweeted
Getting hands-on with some breakout sessions 😎😎 #Irad #FutureRadRes @SIRRFS
1
3
10
928
Still time for 1st year underrepresented medical students to receive an incredible introduction to Radiology via ACR's summer PIER program. See link for more info and application. DEADLINE is Jan 7! #medtwitter #radtwitter #mentorship acr.org/Member-Resources/Med…
1
10
3
19
4,238
For tomorrow's #TakeoverTuesday we have Mirindi Kabangu! Mirindi is a double major in Biology and Biochemistry from DR Congo! 🇨🇩He is incredibly involved on campus as UK ChemCats Vicepresident, BLC Tutor and a K Board member. You can't miss it! @UKarts_sciences
1
2
Mirindi Kabangu retweeted
Great story about @SCoBIRC #AARTS alumni Mirindi Kabangu. 👇
READ: "Mirindi Kabangu: Diversity Supplement Award Helps Scholar Jumpstart His Dream Career." Learn about @Mirindi_'s educational journey, the impact mentors have had on his success, and his plans to pursue an M.D./Ph.D. degree. #ScienceTwitter orip.nih.gov/about-orip/rese…
2
3
Mirindi Kabangu retweeted
READ: "Mirindi Kabangu: Diversity Supplement Award Helps Scholar Jumpstart His Dream Career." Learn about @Mirindi_'s educational journey, the impact mentors have had on his success, and his plans to pursue an M.D./Ph.D. degree. #ScienceTwitter orip.nih.gov/about-orip/rese…